These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17692123)
1. Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. Fortuny J; Kogevinas M; Zens MS; Schned A; Andrew AS; Heaney J; Kelsey KT; Karagas MR BMC Urol; 2007 Aug; 7():13. PubMed ID: 17692123 [TBL] [Abstract][Full Text] [Related]
2. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Fortuny J; Kogevinas M; Garcia-Closas M; Real FX; Tardón A; Garcia-Closas R; Serra C; Carrato A; Lloreta J; Rothman N; Villanueva C; Dosemeci M; Malats N; Silverman D Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1696-702. PubMed ID: 16985032 [TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. Daugherty SE; Pfeiffer RM; Sigurdson AJ; Hayes RB; Leitzmann M; Schatzkin A; Hollenbeck AR; Silverman DT Am J Epidemiol; 2011 Apr; 173(7):721-30. PubMed ID: 21367875 [TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Castelao JE; Yuan JM; Gago-Dominguez M; Yu MC; Ross RK Br J Cancer; 2000 Apr; 82(7):1364-9. PubMed ID: 10755416 [TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study. Genkinger JM; De Vivo I; Stampfer MJ; Giovannucci E; Michaud DS Int J Cancer; 2007 May; 120(10):2221-5. PubMed ID: 17290403 [TBL] [Abstract][Full Text] [Related]
6. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study. Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488 [TBL] [Abstract][Full Text] [Related]
7. Analgesic therapy and the prevention of bladder cancer. Blumentals WA; Foulis PR; Schwartz SW; Mason TJ Urol Oncol; 2004; 22(1):11-5. PubMed ID: 14969797 [TBL] [Abstract][Full Text] [Related]
8. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study. Torti DC; Christensen BC; Storm CA; Fortuny J; Perry AE; Zens MS; Stukel T; Spencer SK; Nelson HH; Karagas MR J Am Acad Dermatol; 2011 Aug; 65(2):304-312. PubMed ID: 21529996 [TBL] [Abstract][Full Text] [Related]
9. Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study. Shih C; Hotaling JM; Wright JL; White E Urol Oncol; 2013 Nov; 31(8):1689-95. PubMed ID: 22795502 [TBL] [Abstract][Full Text] [Related]
10. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies. Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239 [TBL] [Abstract][Full Text] [Related]
11. [Use of analgesics and aspirin in a Spanish multicenter study]. Fortuny J; Silverman D; Malats N; Tardón A; García-Closas R; Serra C; Carrato A; Rothman N; Dosemeci M; Kogevinas M Gac Sanit; 2005; 19(4):316-20. PubMed ID: 16050968 [TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England. Baris D; Karagas MR; Koutros S; Colt JS; Johnson A; Schwenn M; Fischer AH; Figueroa JD; Berndt SI; Han S; Beane Freeman LE; Lubin JH; Cherala S; Cantor KP; Jacobs K; Chanock S; Chatterjee N; Rothman N; Silverman DT Int J Cancer; 2013 Jan; 132(1):162-73. PubMed ID: 22505343 [TBL] [Abstract][Full Text] [Related]
13. Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies. Zhang H; Jiang D; Li X PLoS One; 2013; 8(7):e70008. PubMed ID: 23894577 [TBL] [Abstract][Full Text] [Related]
14. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Jones P; Dalziel SR; Lamdin R; Miles-Chan JL; Frampton C Cochrane Database Syst Rev; 2015 Jul; (7):CD007789. PubMed ID: 26130144 [TBL] [Abstract][Full Text] [Related]
15. Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark. Hannibal CG; Dehlendorff C; Kjaer SK Gynecol Oncol; 2018 Dec; 151(3):513-518. PubMed ID: 30249529 [TBL] [Abstract][Full Text] [Related]
16. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study. Baandrup L Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052 [TBL] [Abstract][Full Text] [Related]
17. Bladder cancer risk in users of selected drugs for cardiovascular disease prevention. Guercio V; Turati F; Bosetti C; Polesel J; Serraino D; Montella M; Libra M; Galfano A; La Vecchia C; Tavani A Eur J Cancer Prev; 2019 Mar; 28(2):76-80. PubMed ID: 29280915 [TBL] [Abstract][Full Text] [Related]
18. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893 [TBL] [Abstract][Full Text] [Related]
19. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Baron JA Prog Exp Tumor Res; 2003; 37():1-24. PubMed ID: 12795046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]